Sunday, April 3, 8:00-9:30 AM
The issue of radiation dose associated with diagnostic imaging can be challenging to clinicians. In this session, attendees will hear from a physicist and a representative from the FDA in what promises to be an interesting view from the technical and regulatory perspective. Clinicians also will discuss risk/benefits associated with imaging with an interesting twist.
- Kevin L. Nelson, PhD, Mayo Clinic, Jacksonville, Fla. -- Diagnostic Imaging Radiation: How Much of a Clinical Issue? View of the Physicist
- Orhan H. Suleiman, PhD, FDA's Center for Drug Evaluation and Research, Rockville, Md. -- Diagnostic Imaging Radiation Exposure: View of a Regulatory Agency
- Rita F. Redberg, MD, University of California, San Francisco -- Assessing Risk in the Face of Benefit
- Jack A. Ziffer, MD, PhD, Miami Cardiac and Vascular Institute, Miami -- Assessing Benefit in the Face of Risk